Nick Leschly
Net Worth
Last updated:
What is Nick Leschly net worth?
The estimated net worth of Mr. Nick Leschly is at least $152,811,301 as of 11 Jan 2023. He owns shares worth $1,397,944 as insider, has earned $142,151,907 from insider trading and has received compensation worth at least $9,261,450 in bluebird bio, Inc..
What is the salary of Nick Leschly?
Mr. Nick Leschly salary is $841,950 per year as Pres & Director in bluebird bio, Inc..
How old is Nick Leschly?
Mr. Nick Leschly is 52 years old, born in 1973.
What stocks does Nick Leschly currently own?
As insider, Mr. Nick Leschly owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
bluebird bio, Inc. (BLUE) | Pres & Director | 280,149 | $4.99 | $1,397,944 |
What does bluebird bio, Inc. do?
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
Nick Leschly insider trading
bluebird bio, Inc.
Mr. Nick Leschly has made 58 insider trades between 2014-2023, according to the Form 4 filled with the SEC. Most recently he sold 4,290 units of BLUE stock worth $33,479 on 11 Jan 2023.
The largest trade he's ever made was exercising 203,355 units of BLUE stock on 4 Mar 2021. As of 11 Jan 2023 he still owns at least 280,149 units of BLUE stock.